Diazoxide Choline in Hypertriglyceridemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alan Forker, MD
St. Luke's Lipid and Diabetes Research Center
Principal Investigator - Andrew Lewin, MD
National Research Institute
Principal Investigator - Craig Thompson, MD
Frederick C. Smith Clinic
Principal Investigator - Cynthia Huffman, MD
Meridien Research
Principal Investigator - David Morin, MD
TriCities Medical Research
Principal Investigator - Eli Roth, MD
Sterling Research Group, Ltd
Principal Investigator - Evan Stein, MD
Metabolic and Atherosclerosis Research Center (MARC)
Principal Investigator - Glibert Weiner, MD
Allied Research International/Cetero Research
Principal Investigator - Harold Bays, MD
L-MARC Research Center
Principal Investigator - Michael Koren, MD
Jacksonville Center For Clinical Research
Principal Investigator - Philip Toth, MD
Midwest Institute for Clinical Research
Principal Investigator - Thomas Littlejohn, MD
Piedmont Medical Research Associates
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- National Research Institute
Los Angeles, California, United States
- Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
- Allied Research International/cetero Research
Miami Gardens, Florida, United States
- Meridien Research
Tampa, Florida, United States
- Midwest Institute for Clinical Research
Indianapolis, Indiana, United States
- L-Marc Research Center
Louisville, Kentucky, United States
- St. Luke'S Lipid and Diabetes Research Center
Kansas City, Missouri, United States
- Piedmont Medical Research Associates
Winston-Salem, North Carolina, United States
- Metabolic and Atherosclerosis Research Center (marc)
Cincinnati, Ohio, United States
- Sterling Research Group, Ltd
Cincinnati, Ohio, United States
- Frederick C. Smith Clinic
Marion, Ohio, United States
- Tricities Medical Research
Bristol, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2008
- Primary completion
- 31 Jan 2009
- Completion
- 31 Mar 2009
- Last update posted
- 8 Nov 2010
- Registered enrollment
- 80
- Registry id
- NCT00696475
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.